Axonics to report first quarter 2023 financial results on may 1

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to report first quarter 2023 financial results after the close of trading on monday, may 1. axonics will host a conference call at 4:30 p.m. eastern time to discuss financial results.
AXNX Ratings Summary
AXNX Quant Ranking